PHARMATECA » Search Articles by Keyword

Found: 8 articles

Article	Edition
V.I. Petrov, O.V. Shatalova, M.S. Klykova, N.P. Stetsky The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus	№12 / 2023
A.E. Bagriy, O.A. Prikolota, A.V. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy, K.A. Kotova Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation	№11-12 / 2022
M.B. Antsiferov (1), O.M. Koteshkova (1), M.S. Novikova (1), N.A. Demidov (2) Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus	№12 / 2021
L.A. Sharonova, A.F. Verbovoy The place of glyflozins in the management of type 2 diabetes mellitus	№4 / 2019
M.B. Antsiferov (1), B.B. Kvasnikov (2) The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)	№4 / 2019
M.B. Antsiferov FEATURES OF USE OF DAPAGLIFLOZIN IN THETREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS	№16 / 2016
G.R. Galstyan HYPOGLYCEMIC EFFECTS OF FLOZINES COMPARED TO SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS	№17 / 2015
E.A. Ushkalova NEW CLASS OF ANTIDIABETIC DRUGS - SODIUM- GLUCOSE COTRANSPORTER INHIBITORS	№16 / 2013